Suchergebnisse - "YO603Y8113"

PubPharm (1.117)

41

Population pharmacokinetics of unbound and total dolutegravir concentrations in children aged 12 years and older : a PK substudy of the SMILE trial

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Abdalla, S. | Compagnucci, A. | Zheng, Y. | +39

42

Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype

enthalten in: Viruses | 2023

von Salvo, P. | Farinacci, D. | Ciccullo, A. | +11

43

Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance

enthalten in: eLife | 2023

von Spielvogel, E. | Lee, S. | Zhou, S. | +9

44

Inflammation and intracellular exposure of dolutegravir, darunavir, tenofovir and emtricitabine in people living with HIV

enthalten in: British journal of clinical pharmacology | 2023

von Ferrara, M. | Cusato, J. | Salvador, E. | +14

45

Evaluation of darunavir-derived HIV-1 protease inhibitors incorporating P2' amide-derivatives : Synthesis, biological evaluation and structural studies

enthalten in: Bioorganic & medicinal chemistry letters | 2023

von Ghosh, A. | Shahabi, D. | Kipfmiller, M. | +7

46

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve (AMBER) and virologically suppressed (EMERALD) participants with neurological and/or psychiatric comorbidities : Week 96 subgroup analysis

enthalten in: HIV medicine | 2023

von Dunn, K. | Bushen, J. | Luo, D. | +3

47

Towards designing of a potential new HIV-1 protease inhibitor using QSAR study in combination with Molecular docking and Molecular dynamics simulations

enthalten in: PloS one | 2023

von Baassi, M. | Moussaoui, M. | Soufi, H. | +4

48

Promising Repurposed Antiviral Molecules to Combat SARS-CoV-2 : A Review

enthalten in: Current pharmaceutical biotechnology | 2023

von Ratan, Y. | Rajput, A. | Jain, V. | +3

49

Exposure and virologic outcomes of dolutegravir combined with ritonavir boosted darunavir in treatment-naïve individuals enrolled in the Netherlands Cohort Study on Acute HIV infection (NOVA)

enthalten in: International journal of antimicrobial agents | 2023

von Prins, H. | Zino, L. | Svensson, E. | +8

50

Long-term follow-up of HIV-1 multi-drug-resistant treatment-experienced participants treated with etravirine, raltegravir and boosted darunavir : towards drug-reduced regimen? ANRS CO3 Aquitaine Cohort 2007-2018

enthalten in: International journal of antimicrobial agents | 2023

von Nyamankolly, E. | Bellecave, P. | Wittkop, L. | +11